Menu
GeneBe

GAMT

guanidinoacetate N-methyltransferase, the group of 7BS small molecule methyltransferases

Basic information

Region (hg38): 19:1397025-1401570

Links

ENSG00000130005NCBI:2593OMIM:601240HGNC:4136Uniprot:Q14353AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • guanidinoacetate methyltransferase deficiency (Definitive), mode of inheritance: AR
  • guanidinoacetate methyltransferase deficiency (Strong), mode of inheritance: AR
  • guanidinoacetate methyltransferase deficiency (Definitive), mode of inheritance: AR
  • guanidinoacetate methyltransferase deficiency (Supportive), mode of inheritance: AR
  • guanidinoacetate methyltransferase deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cerebral creatine deficiency syndrome 2 (Guanidinoacetate methyltransferase deficiency)ARBiochemicalThe condition involves neurologic sequelae, and medical (eg, with creatine-monohydrate, L-ornithine, and/or sodium benzoate) as well as dietary (eg, with ornithine supplementation and protein/arginine restriction) has been reported to increase cerebral creatine, resulting in improvement or stabilization of clinical manifestations in all symptomatic individualsBiochemical; Neurologic7808840; 8651275; 9386672; 11196109; 15651030; 17171576; 17336114; 19027335; 20301745; 23031365; 24268530; 34389248

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GAMT gene.

  • Cerebral creatine deficiency syndrome (465 variants)
  • Deficiency of guanidinoacetate methyltransferase (202 variants)
  • not provided (118 variants)
  • Inborn genetic diseases (61 variants)
  • not specified (58 variants)
  • Leigh syndrome (6 variants)
  • Mitochondrial complex I deficiency (6 variants)
  • GAMT-related condition (2 variants)
  • Intellectual disability (2 variants)
  • See cases (1 variants)
  • Seizure;Intellectual disability (1 variants)
  • Abnormality of the nervous system (1 variants)
  • Guanidinoacetate methyltransferase (GAMT) deficiency (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAMT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
122
clinvar
2
clinvar
129
missense
5
clinvar
20
clinvar
187
clinvar
3
clinvar
3
clinvar
218
nonsense
14
clinvar
8
clinvar
2
clinvar
24
start loss
2
clinvar
2
frameshift
25
clinvar
14
clinvar
2
clinvar
41
inframe indel
1
clinvar
1
clinvar
5
clinvar
7
splice donor/acceptor (+/-2bp)
2
clinvar
9
clinvar
1
clinvar
12
splice region
1
12
18
1
32
non coding
9
clinvar
58
clinvar
16
clinvar
83
Total 49 52 211 183 21

Highest pathogenic variant AF is 0.000164

Variants in GAMT

This is a list of pathogenic ClinVar variants found in the GAMT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-1397048-G-C Leigh syndrome • Deficiency of guanidinoacetate methyltransferase • Mitochondrial complex I deficiency Benign/Likely benign (Jun 19, 2018)328343
19-1397067-G-A Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jan 13, 2018)891814
19-1397083-G-A Mitochondrial complex I deficiency • Deficiency of guanidinoacetate methyltransferase • Leigh syndrome Benign/Likely benign (Jun 19, 2018)328344
19-1397120-G-A Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jan 12, 2018)891815
19-1397208-A-G Mitochondrial complex I deficiency • Leigh syndrome • Deficiency of guanidinoacetate methyltransferase Benign/Likely benign (Jun 14, 2018)328345
19-1397213-T-G Mitochondrial complex I deficiency • Deficiency of guanidinoacetate methyltransferase • Leigh syndrome Benign/Likely benign (Jun 14, 2018)328346
19-1397223-G-T Deficiency of guanidinoacetate methyltransferase Likely benign (Jan 13, 2018)889367
19-1397243-G-A Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jan 12, 2018)889368
19-1397270-G-T Deficiency of guanidinoacetate methyltransferase Likely benign (Jul 26, 2018)889369
19-1397290-C-T Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jan 12, 2018)889370
19-1397342-C-T not specified Likely benign (Oct 07, 2015)380976
19-1397348-G-A not specified • Deficiency of guanidinoacetate methyltransferase Benign (Jun 06, 2022)204598
19-1397357-G-C Likely benign (Jan 25, 2019)377910
19-1397363-C-G Cerebral creatine deficiency syndrome • Deficiency of guanidinoacetate methyltransferase • Inborn genetic diseases Uncertain significance (Jun 06, 2022)205596
19-1397365-T-A Cerebral creatine deficiency syndrome • Inborn genetic diseases Conflicting classifications of pathogenicity (Feb 05, 2024)2137773
19-1397368-G-A Deficiency of guanidinoacetate methyltransferase Uncertain significance (Sep 04, 2020)990516
19-1397369-G-A Cerebral creatine deficiency syndrome • Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jun 06, 2022)544252
19-1397373-C-T Cerebral creatine deficiency syndrome Uncertain significance (Oct 25, 2021)1389310
19-1397377-G-A Cerebral creatine deficiency syndrome Likely benign (Nov 17, 2023)1952122
19-1397378-G-A Cerebral creatine deficiency syndrome Uncertain significance (Dec 19, 2021)2071598
19-1397380-C-A Cerebral creatine deficiency syndrome Likely benign (Sep 03, 2023)2074520
19-1397380-C-T Cerebral creatine deficiency syndrome Likely benign (Jan 09, 2024)1098220
19-1397381-G-A Cerebral creatine deficiency syndrome • Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jun 06, 2022)205595
19-1397392-T-C Cerebral creatine deficiency syndrome Likely benign (Jan 30, 2024)2714266
19-1397393-G-A Deficiency of guanidinoacetate methyltransferase Uncertain significance (Jun 06, 2022)205594

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GAMTprotein_codingprotein_codingENST00000447102 54479
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.009480.828125517081255250.0000319
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.08721531501.020.000008581699
Missense in Polyphen4646.0210.99954506
Synonymous0.02466464.30.9960.00000399550
Loss of Function1.1147.240.5533.11e-784

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001340.000123
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00003630.0000353
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts guanidinoacetate to creatine, using S- adenosylmethionine as the methyl donor (PubMed:26003046, PubMed:24415674, PubMed:26319512). Important in nervous system development (PubMed:24415674). {ECO:0000269|PubMed:24415674, ECO:0000269|PubMed:26003046, ECO:0000269|PubMed:26319512}.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Glycine, serine and threonine metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Dihydropyrimidine Dehydrogenase Deficiency (DHPD);MECP2 and Associated Rett Syndrome;Urea cycle and metabolism of amino groups;Metabolism of polyamines;Metabolism of amino acids and derivatives;Glycine Serine metabolism;Metabolism;Arginine Proline metabolism;creatine biosynthesis;Creatine metabolism (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.140
rvis_EVS
-0.09
rvis_percentile_EVS
46.74

Haploinsufficiency Scores

pHI
0.0969
hipred
N
hipred_score
0.170
ghis
0.520

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.955

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gamt
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; cellular phenotype;

Gene ontology

Biological process
creatine metabolic process;creatine biosynthetic process;muscle contraction;spermatogenesis;animal organ morphogenesis;methylation;regulation of multicellular organism growth;S-adenosylhomocysteine metabolic process;S-adenosylmethionine metabolic process
Cellular component
nucleus;cytoplasm;cytosol
Molecular function
methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity;guanidinoacetate N-methyltransferase activity